Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00965055 · ClinicalTrials.gov registry record · Phase 3
Ezetimibe in Patients Hypo-responsive to Statins
A Phase 3 study, sponsored by University of California, San Diego.
- Terminated
- Registry status
- Phase 3
- Development phase
- 2
- Enrollment target
NCT00965055 is a Phase 3 study that was terminated before completion, run by University of California, San Diego. The registered enrollment target is 2 participants.
The verdict
NCT00965055, a Phase 3 study, was terminated before completion, sponsored by University of California, San Diego.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 2 participants
- Enrollment target
Study Summary
Response to statin therapy for elevated low density lipoprotein is variable and may be influenced by cholesterol absorption. This study will evaluate whether combination therapy with atorvastatin/ezetimibe will be superior to atorvastatin alone in subjects who have less than 25% LDL reduction on starting dose statin (eg, atorvastatin 10 mg daily or simvastatin 20 mg daily).
Interventions
- DRUG Ezetimibe
- DRUG Atorvastatin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2009-09 |
| Est. Completion | 2012-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00965055
The ClinicalTrials.gov registry entry for NCT00965055 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ezetimibe is the first listed.
NCT00965055 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00965055 about?
NCT00965055 is a clinical study titled "Ezetimibe in Patients Hypo-responsive to Statins". Response to statin therapy for elevated low density lipoprotein is variable and may be influenced by cholesterol absorption. This study will evaluate whether combination therapy with atorvastatin/ezetimibe will be superior to atorvastatin alone in subjects who have less than 25% LDL reduction on sta...
What is the current status of trial NCT00965055?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 2 participants. The study started on 2009-09. Estimated completion is 2012-09.
What interventions are being tested in trial NCT00965055?
The interventions under investigation include: Ezetimibe (DRUG), Atorvastatin (DRUG).
Who is sponsoring clinical trial NCT00965055?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.